Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 19,450
-600 (-2.99%)
Jan 19, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 865.33 billion as of January 16, 2026.
Market Cap
865.33B
Enterprise Value
811.91B
Revenue
46.65B
Ranking
n/a
PE Ratio
12.85
Stock Price
19,450.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 865.33B, an increase of 362.97%. That is a compound annual growth rate of 315.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 892.02B | 2.56% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 88.92T |
| Celltrion | 45.18T |
| ALTEOGEN | 26.53T |
| ABL Bio | 10.84T |
| SK Biopharmaceuticals | 9.26T |
| Yuhan | 7.91T |
| HLB Co., Ltd. | 6.83T |
| Sam Chun Dang Pharm. | 6.43T |